<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Quinupristin</strong></td></tr><tr><th>Accession Number</th><td><strong>DB01369</strong></td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>Quinupristin/dalfopristin is a combination of two antibiotics used to treat infections by staphylococci and by vancomycin-resistant Enterococcus faecium. Dalfopristin inhibits the early phase of protein synthesis in the bacterial ribosome and quinupristin inhibits the late phase of protein synthesis. The combination of the two components acts synergistically and is more effective in vitro than each component alone.</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB01369/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB01369/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01369.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01369.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01369.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01369.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01369.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB01369">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Salts</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand names</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand mixtures</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="mixtures"><thead><tr><th>Brand Name</th><th>Ingredients</th></tr></thead><tbody><tr><td>Synercid</td><td>Dalfopristin + Quinupristin</td></tr></tbody></table></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/anti-bacterial-agents">Anti-Bacterial Agents</a></li></ul></td></tr><tr><th>CAS number</th><td>120138-50-3</td></tr><tr><th>Weight</th><td>Average: 1022.218<br>Monoisotopic: 1021.473160099</td></tr><tr><th>Chemical Formula</th><td>C<sub>53</sub>H<sub>67</sub>N<sub>9</sub>O<sub>10</sub>S</td></tr><tr><th>InChI Key</th><td>WTHRRGMBUAHGNI-MJWHERSYSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C53H67N9O10S/c1-6-37-50(68)61-23-11-14-38(61)51(69)59(5)40(26-32-16-18-36(19-17-32)58(3)4)52(70)62-28-35(30-73-43-29-60-24-20-33(43)21-25-60)42(64)27-39(62)47(65)57-45(34-12-8-7-9-13-34)53(71)72-31(2)44(48(66)55-37)56-49(67)46-41(63)15-10-22-54-46/h7-10,12-13,15-19,22,31,33,35,37-40,43-45,63H,6,11,14,20-21,23-30H2,1-5H3,(H,55,66)(H,56,67)(H,57,65)/t31-,35?,37-,38+,39?,40+,43-,44+,45+/m1/s1</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">N-[(3S,6S,12R,15S,16R,19S)-25-{[(3S)-1-azabicyclo[2.2.2]octan-3-ylsulfanyl]methyl}-3-{[4-(dimethylamino)phenyl]methyl}-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentaazatricyclo[20.4.0.0^{6,10}]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide</div></td></tr><tr><th>SMILES</th><td><div class="wrap">CC[C@H]1NC(=O)[C@@H](NC(=O)C2=NC=CC=C2O)[C@@H](C)OC(=O)[C@@H](NC(=O)C2CC(=O)C(CS[C@@H]3CN4CCC3CC4)CN2C(=O)[C@H](CC2=CC=C(C=C2)N(C)C)N(C)C(=O)[C@@H]2CCCN2C1=O)C1=CC=CC=C1</div></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Organic Acids and Derivatives</td></tr><tr><th>Class</th><td>Carboxylic Acids and Derivatives</td></tr><tr><th>Subclass</th><td>Amino Acids, Peptides, and Analogues</td></tr><tr><th>Direct parent</th><td>Cyclic Depsipeptides</td></tr><tr><th>Alternative parents</th><td>Macrolide Lactams; Alpha Amino Acid Esters; Macrolactams; N-acyl-alpha Amino Acids and Derivatives; Pyridinecarboxamides; Quinuclidines; Piperidinones; Benzene and Substituted Derivatives; Pyrrolidines; Tertiary Carboxylic Acid Amides; Tertiary Amines; Secondary Carboxylic Acid Amides; Ketones; Carboxylic Acid Esters; Polyamines; Enolates; Carboxylic Acids; Thioethers</td></tr><tr><th>Substituents</th><td>macrolide lactam; macrolactam; n-acyl-alpha amino acid or derivative; alpha-amino acid ester; pyridinecarboxamide; pyridine carboxylic acid or derivative; quinuclidine; piperidinone; pyridine; benzene; piperidine; pyrrolidine; tertiary carboxylic acid amide; tertiary amine; carboxamide group; carboxylic acid ester; secondary carboxylic acid amide; ketone; thioether; carboxylic acid; enolate; polyamine; organonitrogen compound; amine; carbonyl group</td></tr><tr><th>Classification description</th><td>This compound belongs to the cyclic depsipeptides. These are natural or synthetic compounds having sequences of amino and hydroxy carboxylic acid residues (usually &#945;-amino and &#945;-hydroxy acids) connected in a ring. The residues are commonly but not necessarily regularly alternating.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For the treatment of bacterial infections (usually in combination with dalfopristin).</td></tr><tr><th>Pharmacodynamics</th><td>Quinupristin is a streptogramin antibiotic, derived from pristinamycin I. By inhibiting the bacterial ribosomal subunits, protein synthesis is inhibited thus leading to eventual bacterial cell death or stasis.</td></tr><tr><th>Mechanism of action</th><td>Quinupristin inhibits the late phase of protein synthesis in the bacterial ribosome. Dalfopristin binds to the 23S portion of the 50S ribosomal subunit, and changes the conformation it, enhancing the binding of quinupristin by a factor of about 100. In addition, it inhibits peptidyl transferase. Quinupristin binds to a nearby site on the 50S ribosomal subunit and prevents elongation of the polypeptide as well as causing incomplete chains to be released.</td></tr><tr><th>Absorption</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td>Moderate.</td></tr><tr><th>Metabolism</th><td class="data-table-container"><p>Quinupristin is converted to two conjugated active major metabolites, one with 
glutathione and one with cysteine.</p></td></tr><tr><th>Route of elimination</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Half life</th><td>3.1 hours</td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Affected organisms</th><td><ul><li>Enteric bacteria and other eubacteria</li></ul></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              -
        </td>
        <td>0.6848</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              -
        </td>
        <td>0.9972</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              -
        </td>
        <td>0.648</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Substrate
        </td>
        <td>0.8607</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.5298</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.6803</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8877</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.7898</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.9116</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Substrate</td>
        <td>0.6413</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8804</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.803</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8539</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.7776</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8954</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.9155</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.7484
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.8552
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.9816
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          2.9306 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.9575
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Inhibitor 
        </td>
        <td>
            0.7598
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://www.dsm.com">DSM Corp.</a></li>
<li>Gruppo Lepetit SPA</li>
<li><a href="http://www.monarch-pharmacy.co.uk">Monarch Pharmacy</a></li>
<li><a href="http://www.sanofi-aventis.com">Sanofi-Aventis Inc.</a></li></ul></td></tr><tr><th>Dosage forms</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Prices</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Patents</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="properties"><th class="divider" colspan="2">Properties</th></tr><tr><th>State</th><td>solid</td></tr><tr><th>Experimental Properties</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Predicted Properties</th><td class="data-table-container"><table class="table table-condensed table-striped"><thead><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr></thead><tbody><tr><td>water solubility</td><td>4.45e-02 g/l</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>logP</td><td>2.99</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>logP</td><td>2.18</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#logp_logd">ChemAxon</a></td></tr><tr><td>logS</td><td>-4.4</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>pKa (strongest acidic)</td><td>7.45</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>pKa (strongest basic)</td><td>8.28</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>physiological charge</td><td>1</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>hydrogen acceptor count</td><td>12</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>hydrogen donor count</td><td>4</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>polar surface area</td><td>231.2</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topolgical_surface">ChemAxon</a></td></tr><tr><td>rotatable bond count</td><td>10</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>refractivity</td><td>272.84</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#refractivity">ChemAxon</a></td></tr><tr><td>polarizability</td><td>107.02</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>number of rings</td><td>8</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>bioavailability</td><td>0</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>rule of five</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Ghose filter</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Veber's rule</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>MDDR-like rule</td><td>Yes</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="references"><th class="divider" colspan="2">References</th></tr><tr><th>Synthesis Reference</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>General Reference</th><td><span class="citations"><ol>
	<li>Allington DR, Rivey MP: Quinupristin/dalfopristin: a therapeutic review. Clin Ther. 2001 Jan;23(1):24-44. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11219478">Pubmed</a></li>
	<li>Lamb HM, Figgitt DP, Faulds D: Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections. Drugs. 1999 Dec;58(6):1061-97. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10651391">Pubmed</a></li>
	<li>Manzella JP: Quinupristin-dalfopristin: a new antibiotic for severe gram-positive infections. Am Fam Physician. 2001 Dec 1;64(11):1863-6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11764864">Pubmed</a></li>
	<li>Paradisi F, Corti G, Messeri D: Antistaphylococcal (<span class="caps">MSSA</span>, <span class="caps">MRSA</span>, <span class="caps">MSSE</span>, <span class="caps">MRSE</span>) antibiotics. Med Clin North Am. 2001 Jan;85(1):1-17. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11190346">Pubmed</a></li>
</ol></span></td></tr><tr><th>External Links</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Resource</th><th>Link</th></tr></thead><tbody><tr><td>KEGG Drug</td><td><a class="wishart-link-out" href="http://www.genome.jp/dbget-bin/www_bget?drug:D00852" target="_blank">D00852 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>KEGG Compound</td><td><a class="wishart-link-out" href="http://www.genome.jp/dbget-bin/www_bget?cpd:C08032" target="_blank">C08032 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Therapeutic Targets Database</td><td><a class="wishart-link-out" href="http://bidd.nus.edu.sg/group/cjttd/ZFTTDDRUG.asp?ID=DAP001288" target="_blank">DAP001288 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PharmGKB</td><td><a class="wishart-link-out" href="http://www.pharmgkb.org/drug/PA164749647" target="_blank">PA164749647 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>HET</td><td><a class="wishart-link-out" href="http://www.ebi.ac.uk/msd-srv/chempdb/cgi-bin/cgi.pl?FUNCTION=getByCode&amp;CODE=SYB" target="_blank">SYB <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Wikipedia</td><td><a class="wishart-link-out" href="http://en.wikipedia.org/wiki/Quinupristin" target="_blank">Quinupristin <span class="glyphicon glyphicon-new-window"> </span></a></td></tr></tbody></table></td></tr><tr><th>ATC Codes</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>AHFS Codes</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>PDB Entries</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>FDA label</th><td><a href="/system/fda_labels/DB01369.pdf?1265922805">show</a>(67.1 KB)</td></tr><tr><th>MSDS</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB00381">Amlodipine</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB01169">Arsenic trioxide</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00637">Astemizole</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB01076">Atorvastatin</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00564">Carbamazepine</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00439">Cerivastatin</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00604">Cisapride</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB01211">Clarithromycin</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00091">Cyclosporine</a></td><td>Synercid increases the effect of cyclosporine</td></tr><tr><td><a href="/drugs/DB00705">Delavirdine</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00829">Diazepam</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB01341">Dihydroquinidine barbiturate</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00343">Diltiazem</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00280">Disopyramide</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB01248">Docetaxel</a></td><td>This combination presents an increased risk of toxicity.</td></tr><tr><td><a href="/drugs/DB00204">Dofetilide</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00450">Droperidol</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00199">Erythromycin</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00773">Etoposide</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00949">Felbamate</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB01023">Felodipine</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB01195">Flecainide</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00529">Foscarnet</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB01320">Fosphenytoin</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB01044">Gatifloxacin</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00365">Grepafloxacin</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB01218">Halofantrine</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00224">Indinavir</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00270">Isradipine</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00528">Lercanidipine</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB01137">Levofloxacin</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB01227">Levomethadyl Acetate</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00281">Lidocaine</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00678">Losartan</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00227">Lovastatin</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00959">Methylprednisolone</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00683">Midazolam</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00691">Moexipril</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00218">Moxifloxacin</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00238">Nevirapine</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00622">Nicardipine</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB01115">Nifedipine</a></td><td>Synercid increases the effect of ziprasidone</td></tr><tr><td><a href="/drugs/DB00393">Nimodipine</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00401">Nisoldipine</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00104">Octreotide</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB01229">Paclitaxel</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00738">Pentamidine</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB01224">Quetiapine</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00908">Quinidine</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB01346">Quinidine barbiturate</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00503">Ritonavir</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00938">Salmeterol</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00641">Simvastatin</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00864">Tacrolimus</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00675">Tamoxifen</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00444">Teniposide</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00342">Terfenadine</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00697">Tizanidine</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00285">Venlafaxine</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00661">Verapamil</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00570">Vinblastine</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00541">Vincristine</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00309">Vindesine</a></td><td>This combination presents an increased risk of toxicity</td></tr><tr><td><a href="/drugs/DB00361">Vinorelbine</a></td><td>This combination presents an increased risk of toxicity</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table>